FibroAction has got an article discussing three recent trials of pregabalin as a treatment for Fibromyalgia Syndrome (Fibro).

Last summer, Pregabalin (brand name Lyrica) was the first medication to be approved by the American Food and Drug Administration (FDA) for “on-label” use as a treatment for Fibromyalgia Syndrome.

FibroAction is a new organisation, basd in the UK, which aims to make accurate, up-to-date information about Fibromyalgia Syndrome (Fibro) readily available, as well as raise awareness of the condition.